Pricing Log in Create free account

Summit Therapeutics PLC (SMMT) vs Twist Bioscience Corporation (TWST)

Summit Therapeutics PLC and Twist Bioscience Corporation are both Biotechnology companies. Summit Therapeutics PLC is the larger, with a market value of $12.8B against $10.1B — 1.3× the size. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against −61.0%. Summit Therapeutics PLC has the higher net margin (0.00% vs −31.7%) and the higher return on invested capital (0.00% vs −30.8%). Across the 18 metrics below, Summit Therapeutics PLC leads on 9 and Twist Bioscience Corporation on 9.

Valuation

Metric SMMT TWST Biotechnology median
P/E n/m n/m 12.43
P/S 17,694.05 22.08 10.53
P/B 19.80 21.39 2.24
Price to free cash flow n/m n/m 22.59
EV/EBITDA n/m n/m 0.69
EV/Sales 16,855.76 21.73 9.92
Earnings yield (6.99%) (1.45%) (34.94%)
Free cash flow yield (3.69%) (1.00%) (23.17%)

Profitability

Metric SMMT TWST Biotechnology median
Gross margin 100.00% 51.97% 68.94%
Operating margin 0.00% (33.58%) 0.00%
Net margin 0.00% (31.66%) 0.00%
Free cash flow margin 0.00% (22.15%) 0.00%
Return on equity (192.50%) (29.59%) (54.09%)
Return on assets (159.09%) (20.78%) (46.84%)
Return on invested capital 0.00% (30.83%) 0.00%

Growth

Metric SMMT TWST Biotechnology median
Revenue growth (TTM) (61.03%) 19.19% 6.72%
EPS growth (last fiscal year) (364.52%) 63.89% 29.36%
Revenue growth, 5-year CAGR (46.49%) 33.11% 9.96%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SMMT TWST Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 6.96 2.67 5.00
Net debt to EBITDA 0.65 1.95 1.01

Dividend

Metric SMMT TWST Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric SMMT TWST Biotechnology median
Market cap 12.79b 10.06b 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack